Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
I-MICRO: Ilomedine in the treatment of septic shock with persistence of microperfusion disorders
2018-001709-10Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jul 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of iloprost in septic shock (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Started Jul 2018; status: completed.
02
Drugs
iloprost
03
Conditions
septic shock
Beyond the preview
Go deeper on 2018-001709-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001709-10.